NextPoint Therapeutics discloses $48.7 million private securities offering
A Form D filed with the SEC shows the Cambridge biotech has sold $33.7 million of a planned $48.7 million equity offering to 15 investors.
SEC filing
Latest
1 story
Sign inSign in1 story
A Form D filed with the SEC shows the Cambridge biotech has sold $33.7 million of a planned $48.7 million equity offering to 15 investors.
SEC filing